Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Stuart J. Connolly, Marcus Flather et al.|The Lancet|2010Cited by 1k
Urinary Sodium and Potassium Excretion and Risk of Cardiovascular EventsMartin O’Donnell, Roland E. Schmieder, Salim Yusuf et al.|JAMA|2011Cited by 566